Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Liuzzi

Showing results (31-40 of 125) with videos related to

Pageof 13
Sort By:
The Journal of Clinical Endocrinology and Metabolism|February 1, 1974
Inhibitory effect of dopaminergic stimulation on GH release in acromegalyP G Chiodini, A Liuzzi, L Botalla, et al.
Folia Endocrinologica|October 1, 1973
[Behavior of plasmatic TSH in pituitary neoplasms after stimulation with thyrotropin releasing hormone (TRH)]F Silvestrini, A Liuzzi, P G Chiodini, et al.
Minerva Endocrinologica|January 1, 1990
[Medical treatment of acromegaly with dopaminergic agents]A Liuzzi, D Dallabonzana, G Oppizzi, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1972
Inhibitory effect of L-Dopa on GH release in acromegalic patientsA Liuzzi, P G Chiodini, L Botalla, et al.
Advances in Biochemical Psychopharmacology|January 1, 1974
A study of the central effects of 5,6-dihydroxytryptamineV G Longo, A Scotti de Carolis, A Liuzzi, et al.
Folia Endocrinologica|December 1, 1973
[Studies of hypothalamic control of somatotropin incretion in acromegaly]A Liuzzi, P G Chiodini, L Botalla, et al.
Annales D'Endocrinologie|July 1, 1972
[STH blood level after metopirone in 12 patients with acromegaly]P G Chiodini, A Liuzzi, F Spinelli, et al.
Journal of Endocrinological Investigation|June 1, 1985
Medical treatment of pituitary adenomas: effects on tumor growthA Liuzzi, P G Chiodini, D Dallabonzana, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1974
Growth hormone (GH)-releasing activity of TRH and GH-lowering effect of dopaminergic drugs in acromegaly: homogeneity in the two responsesA Liuzzi, P G Chiodini, L Botalla, et al.
Diabetes, Obesity & Metabolism|March 31, 2007
Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patientsA Brunani, A Caumo, S Graci, et al.
Pageof 13

Showing results (31-40 of 125) with videos related to

Sort By:
Pageof 13
The Journal of Clinical Endocrinology and Metabolism|February 1, 1974
Inhibitory effect of dopaminergic stimulation on GH release in acromegalyP G Chiodini, A Liuzzi, L Botalla, et al.
Folia Endocrinologica|October 1, 1973
[Behavior of plasmatic TSH in pituitary neoplasms after stimulation with thyrotropin releasing hormone (TRH)]F Silvestrini, A Liuzzi, P G Chiodini, et al.
Minerva Endocrinologica|January 1, 1990
[Medical treatment of acromegaly with dopaminergic agents]A Liuzzi, D Dallabonzana, G Oppizzi, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1972
Inhibitory effect of L-Dopa on GH release in acromegalic patientsA Liuzzi, P G Chiodini, L Botalla, et al.
Advances in Biochemical Psychopharmacology|January 1, 1974
A study of the central effects of 5,6-dihydroxytryptamineV G Longo, A Scotti de Carolis, A Liuzzi, et al.
Folia Endocrinologica|December 1, 1973
[Studies of hypothalamic control of somatotropin incretion in acromegaly]A Liuzzi, P G Chiodini, L Botalla, et al.
Annales D'Endocrinologie|July 1, 1972
[STH blood level after metopirone in 12 patients with acromegaly]P G Chiodini, A Liuzzi, F Spinelli, et al.
Journal of Endocrinological Investigation|June 1, 1985
Medical treatment of pituitary adenomas: effects on tumor growthA Liuzzi, P G Chiodini, D Dallabonzana, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1974
Growth hormone (GH)-releasing activity of TRH and GH-lowering effect of dopaminergic drugs in acromegaly: homogeneity in the two responsesA Liuzzi, P G Chiodini, L Botalla, et al.
Diabetes, Obesity & Metabolism|March 31, 2007
Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patientsA Brunani, A Caumo, S Graci, et al.
Pageof 13